Your email has been successfully added to our mailing list.

×
0 0 -0.019607843137255 -0.019607843137255 -0.000933706816059837 -0.000933706816059837 -0.000933706816059837 -0.000933706816059837
Stock impact report

Jazz Pharmaceuticals (NASDAQ:JAZZ) Reports Q2 In Line With Expectations But Stock Drops [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
Company Research Source: Yahoo! Finance
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) met Wall Street's revenue expectations in Q2 CY2025, with sales up 2.1% year on year to $1.05 billion. The company's outlook for the full year was close to analysts' estimates with revenue guided to $4.23 billion at the midpoint. Its non-GAAP loss of $8.25 per share was 32.1% below analysts' consensus estimates. Show less Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for JAZZ alerts
Opt-in for
JAZZ alerts

from News Quantified
Opt-in for
JAZZ alerts

from News Quantified